View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Study - HOVON 132 AML / SAKK 30/13 - B - Daunorubicin 60 / Cytarabine 1000 / Lenalidomide 20, Induction, Acute Myeloid Leukemia, Cycle 2
Protocol-ID: 1066 V1.1 (Mini), STUDY-HOVON 132 AML / SAKK 30/13 - B - DAUN60/CYTA1000/LENA20, Ind., AML, C2Study protocol, available to authorized participants only.
Indication(s)
- Acute Myeloid Leukemia; ICD-10 C92.0-, C92.5-, C93.0-, C92.8-, C92.6-, C92.7-, C92.9-
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 02.04.2021